Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Alvotech (ALVOW) EBT (2021 - 2025)

Historic EBT for Alvotech (ALVOW) over the last 5 years, with Q3 2025 value amounting to -$275.9 million.

  • Alvotech's EBT fell 101455.76% to -$275.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$390.7 million, marking a year-over-year increase of 5259.66%. This contributed to the annual value of -$217.6 million for FY2024, which is 6658.27% up from last year.
  • Per Alvotech's latest filing, its EBT stood at -$275.9 million for Q3 2025, which was down 101455.76% from $327.9 million recorded in Q2 2025.
  • Alvotech's 5-year EBT high stood at $327.9 million for Q2 2025, and its period low was -$651.0 million during Q4 2023.
  • Moreover, its 5-year median value for EBT was -$106.4 million (2022), whereas its average is -$127.4 million.
  • Over the last 5 years, Alvotech's EBT had its largest YoY gain of 32133.31% in 2025, and its largest YoY loss of 9990000.0% in 2025.
  • Over the past 5 years, Alvotech's EBT (Quarter) stood at $254.0 million in 2021, then plummeted by 317.17% to -$551.6 million in 2022, then decreased by 18.02% to -$651.0 million in 2023, then soared by 66.58% to -$217.6 million in 2024, then dropped by 26.79% to -$275.9 million in 2025.
  • Its EBT stands at -$275.9 million for Q3 2025, versus $327.9 million for Q2 2025 and -$225.2 million for Q1 2025.